Cargando…
Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer
Triple-negative breast cancer (TNBC), defined as loss of estrogen, progesterone, and Her2 receptors, is a subtype of highly aggressive breast cancer with worse prognosis and poor survival rate. Macrophage migration inhibitory factor (MIF) is a pleiotropic pro-inflammatory cytokine aberrantly express...
Autores principales: | Charan, Manish, Das, Subhadip, Mishra, Sanjay, Chatterjee, Nabanita, Varikuti, Sanjay, Kaul, Kirti, Misri, Swati, Ahirwar, Dinesh K., Satoskar, Abhay R., Ganju, Ramesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498597/ https://www.ncbi.nlm.nih.gov/pubmed/32943608 http://dx.doi.org/10.1038/s41419-020-02992-y |
Ejemplares similares
-
Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2
por: Misri, Swati, et al.
Publicado: (2022) -
Slit2/Robo1 signaling inhibits small‐cell lung cancer by targeting β‐catenin signaling in tumor cells and macrophages
por: Ahirwar, Dinesh K., et al.
Publicado: (2023) -
Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer
por: Charan, Manish, et al.
Publicado: (2020) -
Racially Disparate Expression of mTOR/ERK-1/2 Allied Proteins in Cancer
por: Mishra, Sanjay, et al.
Publicado: (2021) -
Fibroblast-Derived CXCL12 Promotes Breast Cancer Metastasis by Facilitating Tumor Cell Intravasation
por: Ahirwar, Dinesh K., et al.
Publicado: (2018)